WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2022)
Top pharmaceutical stocks in 2022 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
VTRS
VIATRIS INC
United States
$10.43B1,212,580,94073.13%17.41%Net SellingNet Selling
RDY
DR REDDYS LABORATORIES LTD
India
$8.69B166,425,8499.40%0.00%
IRWD
IRONWOOD PHARMACEUTICALS INC
United States
$1.59B153,231,13073.63%26.37%Net SellingNet Selling
ACRX
ACELRX PHARMACEUTICALS INC
United States
$31.23M147,331,96311.61%29.17%Net Selling
PAHC
PHIBRO ANIMAL HEALTH CORP
United States
$533.43M40,503,60844.97%55.03%
CTLT
CATALENT INC
United States
$13.36B179,895,67779.85%20.15%Net BuyingNet Selling
SLDB
SOLID BIOSCIENCES INC
United States
$52.88M112,989,77346.41%53.59%Net Selling
PCRX
PACIRA BIOSCIENCES INC
United States
$2.49B45,824,21068.81%31.19%Net BuyingNet Selling
AMPH
AMPHASTAR PHARMACEUTICALS INC
United States
$1.42B49,015,17253.68%46.32%Net SellingNet Selling
ASRT
ASSERTIO HOLDINGS INC
United States
$104.55M48,178,24528.52%38.96%Net Selling
PRPH
PROPHASE LABS INC
United States
$180.39M16,006,22212.25%60.11%Net BuyingNet Buying
ZTS
ZOETIS INC
United States
$70.67B468,138,56890.18%5.48%Net SellingNet Buying
OGI
ORGANIGRAM HOLDINGS INC
Canada
$284.22M313,707,76711.81%0.00%
AMYT
AMRYT PHARMA PLC
United Kingdom
$458.22M320,884,82213.98%0.00%
CALT
CALLIDITAS THERAPEUTICS AB
Sweden
$428.82M59,106,1881.47%0.00%
CRON
CRONOS GROUP INC
Canada
$1.11B377,896,37112.02%48.05%Net BuyingNet Buying
ACB
AURORA CANNABIS INC
Canada
$372.22M297,772,23816.89%0.00%
ORGO
ORGANOGENESIS HOLDINGS INC
United States
$425.39M130,887,8176.24%93.76%Net BuyingNet Buying
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
Israel
$1.08B37,587,23111.33%50.73%
SNDL
SNDL INC
Canada
$523.58M237,993,11952.85%0.00%
GHSI
GUARDION HEALTH SCIENCES INC
United States
$8.50M61,600,8037.31%25.72%Net Selling
DRRX
DURECT CORP
United States
$134.38M227,764,01942.77%41.89%Net BuyingNet Buying
BFRI
BIOFRONTERA INC
United States
$23.55M23,550,9606.84%34.69%
TLRY
TILRAY BRANDS INC
Canada
$1.53B536,390,76612.06%2.59%Net SellingNet Selling
SBFM
SUNSHINE BIOPHARMA INC
Canada
$14.54M18,885,6323.90%0.82%Net Selling
TKNO
ALPHA TEKNOVA INC
United States
$96.07M28,090,48424.58%75.42%Net BuyingNet Buying
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
China
$43.62M35,750,0000.09%0.00%
OPTN
OPTINOSE INC
United States
$289.81M83,277,50439.67%22.82%Net SellingNet Selling
EGRX
EAGLE PHARMACEUTICALS INC
United States
$379.94M13,284,55925.85%74.15%Net SellingNet Selling
EOLS
EVOLUS INC
United States
$435.30M56,094,78045.19%29.72%Net SellingNet Selling
SCYX
SCYNEXIS INC
United States
$76.41M32,651,77850.03%22.31%Net Buying
PLXP
PLX PHARMA INC
United States
$14.79M28,172,46827.55%25.72%Net Buying
ZYNE
ZYNERBA PHARMACEUTICALS INC
United States
$35.78M45,753,07924.00%7.09%Net SellingNet Selling
HUGE
FSD PHARMA INC
Canada
$31.60M38,491,3451.26%0.00%
EBS
EMERGENT BIOSOLUTIONS INC
United States
$1.04B49,861,50946.20%53.80%Net Selling
CGC
CANOPY GROWTH CORP
Canada
$1.33B479,978,74210.30%57.63%Net Buying
ZOM
ZOMEDICA CORP
United States
$207.75M979,949,6689.65%6.70%Net Buying
DERM
JOURNEY MEDICAL CORP
United States
$44.17M17,596,49310.00%16.08%
EVOK
EVOKE PHARMA INC
United States
$6.25M3,343,0700.59%99.41%
INCR
INTERCURE LTD
Israel
$203.55M45,133,94514.19%0.00%
FLGC
FLORA GROWTH CORP
Canada
$52.71M76,944,0005.64%0.00%
SUPN
SUPERNUS PHARMACEUTICALS INC
United States
$1.78B53,495,26144.16%55.84%Net SellingNet Selling
VERU
VERU INC
United States
$939.32M80,146,73551.51%48.49%Net BuyingNet Buying
ANIP
ANI PHARMACEUTICALS INC
United States
$551.53M17,436,89816.74%83.26%Net SellingNet Selling
AGRX
AGILE THERAPEUTICS INC
United States
$11.08M39,023,0232.47%97.53%Net BuyingNet Buying
JUPW
JUPITER WELLNESS INC
United States
$15.77M21,513,88814.43%35.82%Net Buying
NLTX
NEOLEUKIN THERAPEUTICS INC
United States
$27.04M42,579,85248.86%41.80%Net SellingNet Selling
PRFX
PAINREFORM LTD
Israel
$6.69M10,634,1660.95%0.00%
BHC
BAUSCH HEALTH COMPANIES INC
Canada
$2.51B361,728,49065.89%30.58%Net SellingNet Selling
SISI
SHINECO INC
China
$13.89M16,397,3560.92%37.03%
ADMP
ADAMIS PHARMACEUTICALS CORP
United States
$33.75M149,983,2658.58%32.51%Net Selling
AERI
AERIE PHARMACEUTICALS INC
United States
$746.32M49,359,91376.89%23.11%Net SellingNet Selling
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
Canada
$11.90M7,989,80013.90%63.79%Net SellingNet Selling
SNOA
SONOMA PHARMACEUTICALS INC
United States
$6.60M3,100,9375.12%94.88%
HEXO
HEXO CORP
Canada
$67.28M382,278,54312.27%0.00%
CRDL
CARDIOL THERAPEUTICS INC
Canada
$63.80M61,939,9998.53%0.00%
ALVO
ALVOTECH
Luxembourg
$1.56B223,718,8978.68%0.00%
HROW
HARROW HEALTH INC
United States
$311.85M27,069,97824.64%75.36%Net Buying
CLVR
CLEVER LEAVES HOLDINGS INC
United States
$25.98M43,012,68118.46%29.39%Net SellingNet Selling
RDHL
REDHILL BIOPHARMA LTD
Israel
$27.88M571,233,0000.71%0.00%
SCTL
SOCIETAL CDMO INC
United States
$92.35M56,657,86032.37%67.63%Net SellingNet Buying
PRGO
PERRIGO CO PLC
Ireland
$4.84B134,618,00161.48%38.52%Net Buying
TAK
TAKEDA PHARMACEUTICAL CO LTD
Japan
$43.22B1,666,098,4373.40%0.00%
THTX
THERATECHNOLOGIES INC
Canada
$218.78M95,121,63922.59%0.00%
CYTH
CYCLO THERAPEUTICS INC
United States
$16.54M8,439,4350.52%99.48%Net BuyingNet Buying
RLMD
RELMADA THERAPEUTICS INC
United States
$1.09B30,060,51881.91%2.62%Net SellingNet Buying
COSM
COSMOS HOLDINGS INC
United States
$5.30M25,977,9946.24%0.11%
KMDA
KAMADA LTD
Israel
$198.02M44,799,79416.14%0.00%
PETQ
PETIQ INC
United States
$215.53M29,565,30485.17%14.83%Net BuyingNet Buying
RMTI
ROCKWELL MEDICAL INC
United States
$13.98M10,675,1935.89%94.11%
VLNS
VALENS COMPANY INC
Canada (Federal Level)
$53.89M80,193,95010.01%0.00%
MDVL
MEDAVAIL HOLDINGS INC
United States
$63.78M80,021,73733.07%66.93%Net BuyingNet Buying
COLL
COLLEGIUM PHARMACEUTICAL INC
United States
$540.56M34,126,20557.20%42.80%Net SellingNet Selling
TXMD
THERAPEUTICSMD INC
United States
$63.43M9,424,8922.38%97.62%Net BuyingNet Buying
SXTC
CHINA SXT PHARMACEUTICALS INC
China
$1.63M2,031,3930.00%0.00%
UPXI
UPEXI INC
United States
$66.18M16,713,3454.25%40.59%Net Buying
CPIX
CUMBERLAND PHARMACEUTICALS INC
United States
$36.51M14,661,93718.47%56.30%Net BuyingNet Buying
HAPP
HAPPINESS DEVELOPMENT GROUP LTD
China
$12.26M79,099,6831.34%0.00%
IXHL
INCANNEX HEALTHCARE LTD
Australia
$108.04M1,292,334,0280.00%0.00%
AKAN
AKANDA CORP
United Kingdom
$13.67M28,909,0261.67%0.00%
PTPI
PETROS PHARMACEUTICALS INC
United States
$10.55M20,684,7233.26%27.68%Net Buying
AVDL
AVADEL PHARMACEUTICALS PLC
Ireland
$290.60M59,793,37156.42%21.81%Net Buying
YCBD
CBDMD INC
United States
$13.99M60,555,59513.75%86.25%
XXII
22ND CENTURY GROUP INC
United States
$202.54M214,784,74119.77%15.41%Net SellingNet Selling
PROC
PROCAPS GROUP SA
Luxembourg
$740.13M112,824,1831.48%76.27%
ELAN
ELANCO ANIMAL HEALTH INC
United States
$6.00B474,113,64790.56%9.44%Net SellingNet Buying
ATNX
ATHENEX INC
United States
$32.59M121,608,38829.34%30.73%Net BuyingNet Buying
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Israel
$8.68B1,110,564,65645.58%0.74%Net SellingNet Selling
LCI
LANNETT CO INC
United States
$19.89M42,959,95930.91%69.09%Net BuyingNet Selling
ALIM
ALIMERA SCIENCES INC
United States
$36.73M6,995,4612.32%97.68%Net Selling
EMBC
EMBECTA CORP
United States
$1.70B57,836,48892.98%0.44%
CPHI
CHINA PHARMA HOLDINGS INC
China
$7.06M50,449,6731.48%67.85%
TCDA
TRICIDA INC
United States
$557.25M55,668,88040.49%59.51%Net BuyingNet Buying
AMRX
AMNEAL PHARMACEUTICALS INC
$634.37M303,525,42532.06%67.94%Net Buying
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
Hong Kong
$398.23M12,642,1050.07%0.00%
BGXX
BRIGHT GREEN CORP
United States
$190.18M159,818,4902.22%72.61%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Oct 2022?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the top pharmaceutical stock with a Zen Score of 61, which is 32 points higher than the pharmaceutical industry average of 29. It passed 21 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -37.95% over the past year, overperforming other pharmaceutical stocks by 2 percentage points.

Viatris has an average 1 year price target of $11.80, an upside of 37.21% from Viatris's current stock price of $8.60.

Viatris stock has a consensus Sell recommendation according to Wall Street analysts. Of the 6 analysts covering Viatris, 0% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second best pharmaceutical stock with a Zen Score of 58, which is 29 points higher than the pharmaceutical industry average of 29. It passed 18 out of 33 due diligence checks and has strong fundamentals. Ironwood Pharmaceuticals has seen its stock lose -21.68% over the past year, overperforming other pharmaceutical stocks by 18 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $14.33, an upside of 38.22% from Ironwood Pharmaceuticals's current stock price of $10.37.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Ironwood Pharmaceuticals, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Dr Reddys Laboratories (NYSE:RDY)


Dr Reddys Laboratories (NYSE:RDY) is the third best pharmaceutical stock with a Zen Score of 58, which is 29 points higher than the pharmaceutical industry average of 29. It passed 22 out of 38 due diligence checks and has strong fundamentals. Dr Reddys Laboratories has seen its stock lose -19.88% over the past year, overperforming other pharmaceutical stocks by 20 percentage points.

Dr Reddys Laboratories has an average 1 year price target of $69.00, an upside of 32.13% from Dr Reddys Laboratories's current stock price of $52.22.

Dr Reddys Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Dr Reddys Laboratories, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 5.47%, which is 3 percentage points higher than the pharmaceutical industry average of 2.49%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 73% indicates that its high dividend yield is sustainable for the long-term.

2. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.64%, which is 1 percentage points higher than the pharmaceutical industry average of 2.49%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 39.7% indicates that its dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 2.84%, which is the same as the pharmaceutical industry average of 2.49%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -114.9% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -1.17% in the last day, and down -0.22% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 55 points higher than the pharmaceutical industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has dropped -37.95% in the past year. It has overperformed other stocks in the pharmaceutical industry by 2 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Ironwood Pharmaceuticals has a valuation score of 86, which is 55 points higher than the pharmaceutical industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has dropped -21.68% in the past year. It has overperformed other stocks in the pharmaceutical industry by 18 percentage points.

3. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 40 points higher than the pharmaceutical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -79.42% in the past year. It has underperformed other stocks in the pharmaceutical industry by -39 percentage points.

Are pharmaceutical stocks a good buy now?

43.75% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 83.97% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 20.52x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.